Clinical Trial Update: Study of Options for Second-Line Effective Combination Therapy (SELECT) [Phase 3]

View source ↗

Summary

A Phase 3 study for second-line effective combination therapy in HIV-1 infection has completed enrollment with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-01-06